Huo L - Search Results

1

The tumor suppressor CYLD regulates microtubule dynamics and plays a role in cell migration.

Gao J, Huo L, Sun X, Liu M, Li D, Dong JT, Zhou J. Gao J, et al. Among authors: huo l. J Biol Chem. 2008 Apr 4;283(14):8802-9. doi: 10.1074/jbc.M708470200. Epub 2008 Jan 24. J Biol Chem. 2008. PMID: 18222923 Free article.

2

CYLD regulates angiogenesis by mediating vascular endothelial cell migration.

Gao J, Sun L, Huo L, Liu M, Li D, Zhou J. Gao J, et al. Among authors: huo l. Blood. 2010 May 20;115(20):4130-7. doi: 10.1182/blood-2009-10-248526. Epub 2010 Mar 1. Blood. 2010. PMID: 20194890 Free article.

3

Tumour suppressor CYLD is a negative regulator of the mitotic kinase Aurora-B.

Sun L, Gao J, Huo L, Sun X, Shi X, Liu M, Li D, Zhang C, Zhou J. Sun L, et al. Among authors: huo l. J Pathol. 2010 Aug;221(4):425-32. doi: 10.1002/path.2723. J Pathol. 2010. PMID: 20593489

4

Tat acetylation regulates its actions on microtubule dynamics and apoptosis in T lymphocytes.

Huo L, Li D, Sun L, Liu M, Shi X, Sun X, Li J, Dong B, Dong X, Zhou J. Huo L, et al. J Pathol. 2011 Jan;223(1):28-36. doi: 10.1002/path.2768. Epub 2010 Sep 6. J Pathol. 2011. PMID: 20821734

5

Regulation of Tat acetylation and transactivation activity by the microtubule-associated deacetylase HDAC6.

Huo L, Li D, Sun X, Shi X, Karna P, Yang W, Liu M, Qiao W, Aneja R, Zhou J. Huo L, et al. J Biol Chem. 2011 Mar 18;286(11):9280-6. doi: 10.1074/jbc.M110.208884. Epub 2011 Jan 10. J Biol Chem. 2011. PMID: 21220424 Free PMC article.

6

Microtubule-associated deacetylase HDAC6 promotes angiogenesis by regulating cell migration in an EB1-dependent manner.

Li D, Xie S, Ren Y, Huo L, Gao J, Cui D, Liu M, Zhou J. Li D, et al. Among authors: huo l. Protein Cell. 2011 Feb;2(2):150-60. doi: 10.1007/s13238-011-1015-4. Epub 2011 Feb 25. Protein Cell. 2011. PMID: 21359602 Free PMC article.

7

Systematic Analysis of the Functions of Lysine Acetylation in the Regulation of Tat Activity.

He M, Zhang L, Wang X, Huo L, Sun L, Feng C, Jing X, Du D, Liang H, Liu M, Hong Z, Zhou J. He M, et al. Among authors: huo l. PLoS One. 2013 Jun 27;8(6):e67186. doi: 10.1371/journal.pone.0067186. Print 2013. PLoS One. 2013. PMID: 23826228 Free PMC article.

8

Modulation of multidrug resistance in cancer cells by the E3 ubiquitin ligase seven-in-absentia homologue 1.

Liu M, Aneja R, Wang H, Sun L, Dong X, Huo L, Joshi H, Zhou J. Liu M, et al. Among authors: huo l. J Pathol. 2008 Mar;214(4):508-14. doi: 10.1002/path.2312. J Pathol. 2008. PMID: 18213731

9

Validating the mitotic kinesin Eg5 as a therapeutic target in pancreatic cancer cells and tumor xenografts using a specific inhibitor.

Liu M, Yu H, Huo L, Liu J, Li M, Zhou J. Liu M, et al. Among authors: huo l. Biochem Pharmacol. 2008 Jul 15;76(2):169-78. doi: 10.1016/j.bcp.2008.04.018. Epub 2008 May 4. Biochem Pharmacol. 2008. PMID: 18539263

10

Modulation of Eg5 activity contributes to mitotic spindle checkpoint activation and Tat-mediated apoptosis in CD4-positive T-lymphocytes.

Liu M, Li D, Sun L, Chen J, Sun X, Zhang L, Huo L, Zhou J. Liu M, et al. Among authors: huo l. J Pathol. 2014 Jun;233(2):138-47. doi: 10.1002/path.4333. Epub 2014 Mar 28. J Pathol. 2014. PMID: 24488929

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,554 results

Search Page

Filters